Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-44.44%
0%
-44.44%
6 Months
-66.67%
0%
-66.67%
1 Year
-64.29%
0%
-64.29%
2 Years
-87.29%
0%
-87.29%
3 Years
-86.61%
0%
-86.61%
4 Years
-91.85%
0%
-91.85%
5 Years
-68.09%
0%
-68.09%
Manitex Capital, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
14.29%
EBIT to Interest (avg)
-0.49
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.13
EV to EBIT
-0.80
EV to EBITDA
-0.80
EV to Capital Employed
0.11
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.14%
ROE (Latest)
-5.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jul'24 - YoY
Jul'24
Jul'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.00
-0.00
Interest
0.00
0.00
Exceptional Items
-1.00
0.20
-600.00%
Consolidate Net Profit
-1.00
0.10
-1,100.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jul 2024 is 0.00% vs 0.00% in Jul 2023
Consolidated Net Profit
YoY Growth in quarter ended Jul 2024 is -1,100.00% vs 107.69% in Jul 2023
Annual Results Snapshot (Consolidated) - Oct'23
Oct'23
Oct'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.40
-0.90
55.56%
Interest
0.00
0.00
Exceptional Items
0.80
0.20
300.00%
Consolidate Net Profit
0.30
-7.30
104.11%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Oct 2023 is 0.00% vs 0.00% in Oct 2022
Consolidated Net Profit
YoY Growth in year ended Oct 2023 is 104.11% vs -87.18% in Oct 2022
About Manitex Capital, Inc. 
Manitex Capital, Inc.
Investment Managers
Manitex Capital Inc. is a Canada-based company that specializes in acquiring interests in companies and participates in increasing shareholder value in these businesses. The Company operates through three segments: diversified investments (investment), biotechnology (biotech) and a pharmaceutical business (pharma). The investment segment holds interests in companies in the life science industry and also invests in marketable securities. Through its subsidiary, ANRis Pharmaceuticals Inc. (ANRis), (the biotechnology segment), the Company specializes in development of the delivery of nucleic acids for therapeutic purposes. Through its subsidiary, Valeo Pharma Inc. (Valeo), (the pharmaceutical segment), the Company acquires and markets specialty pharmaceutical products and also markets and distributes third-party pharmaceutical products. VPI Pharmaceuticals Inc. is the subsidiary of the Valeo.






